Incyte (INCY) Shares Outstanding (2010 - 2026)

Incyte's (INCY) quarterly Shares Outstanding (Entity) came in at $201.0 million in Q2 2026, up 3.53% YoY from $194.1 million in Q2 2025, and up 0.51% on a QoQ basis from $199.9 million in Q1 2026.

Incyte (INCY) Shares Outstanding (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Shares Outstanding (Entity) data on file, last reported at $201.0 million in Q2 2026.

  • Quarterly Shares Outstanding (Entity) rose 3.53% year-over-year to $201.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $201.0 million (up 3.53% YoY) and the FY2025 annual result came in at $198.5 million, up 2.6% from the prior year.
  • Shares Outstanding (Entity) grew to $201.0 million in Q2 2026, from $199.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $224.5 million in Q1 2024 to a low of $191.6 million in Q2 2024.
  • A 5-year average of $209.4 million and a median of $211.2 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) decreased 14.22% — and 2026, when it advanced 3.53%.
  • Tracing INCY's Shares Outstanding (Entity) over 5 years: stood at $222.7 million in 2022, then rose by 0.69% to $224.3 million in 2023, then retreated by 13.76% to $193.4 million in 2024, then increased by 2.6% to $198.5 million in 2025, then advanced by 1.27% to $201.0 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $201.0 million (Q2 2026), $199.9 million (Q1 2026), and $198.5 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn 200.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 200.38 Mn
Mar 31, 2026 199.34 Mn
Dec 31, 2025 195.20 Mn
Sep 30, 2025 195.67 Mn
Jun 30, 2025 194.00 Mn
Mar 31, 2025 193.71 Mn
Dec 31, 2024 207.11 Mn
Sep 30, 2024 192.63 Mn
Jun 30, 2024 218.18 Mn
Mar 31, 2024 224.48 Mn
Dec 31, 2023 223.63 Mn
Sep 30, 2023 224.08 Mn
Jun 30, 2023 223.25 Mn
Mar 31, 2023 222.96 Mn
Dec 31, 2022 222.00 Mn
Sep 30, 2022 222.42 Mn
Jun 30, 2022 221.66 Mn
Mar 31, 2022 221.33 Mn
Dec 31, 2021 220.43 Mn
Sep 30, 2021 220.85 Mn